Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

A warning about TAVR | Trends in care for the tricuspid & mitral valves | Accurate AI | PE funds deal for stroke drug

News You Need to Know Today
A warning about TAVR | Trends in care for the tricuspid & mitral valves | Accurate AI | PE funds deal for stroke drug
Tuesday, November 7, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Surgeons warn it is too early to recommend a TAVR-first strategy for low-risk patients

The Society of Thoracic Surgeons and European Association for Cardio-Thoracic Surgery say more information is still required before any conclusions can be made about the long-term benefits of TAVR in low-risk patients.

READ MORE >
While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common. Top 10 reasons for readmission after heart transplant.
Share on Twitter Share on Facebook Share on Linkedin

Surgeons warn it is too early to recommend a TAVR-first strategy for low-risk patients

Share on Twitter Share on Facebook Share on Linkedin
While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common. Top 10 reasons for readmission after heart transplant.
The Society of Thoracic Surgeons and European Association for Cardio-Thoracic Surgery say more information is still required before any conclusions can be made about the long-term benefits of TAVR in low-risk patients.
READ MORE >

Key trends in transcatheter tricuspid and mitral valve technologies

The mitral valve has been an especially challenging target for transcatheter interventions, but there are reasons to think key breakthroughs are on the horizon. We talked to Kendra Grubb, MD, about this and other ongoing trends at TCT 2023. 

READ MORE >
Video of Kendra Grubb discussing transcatheter tricuspid and mitral advancements at TCT 2023.
Share on Twitter Share on Facebook Share on Linkedin

Key trends in transcatheter tricuspid and mitral valve technologies

Share on Twitter Share on Facebook Share on Linkedin
Video of Kendra Grubb discussing transcatheter tricuspid and mitral advancements at TCT 2023.
The mitral valve has been an especially challenging target for transcatheter interventions, but there are reasons to think key breakthroughs are on the horizon. We talked to Kendra Grubb, MD, about this and other ongoing trends at TCT 2023. 
READ MORE >

AI model for predicting sudden cardiac death more accurate than expected

The new-look algorithm, trained and validated with data from more than 25,000 patients, scans a patient's electronic health record and identifies signs of trouble. 

READ MORE >
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).
Share on Twitter Share on Facebook Share on Linkedin

AI model for predicting sudden cardiac death more accurate than expected

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).
The new-look algorithm, trained and validated with data from more than 25,000 patients, scans a patient's electronic health record and identifies signs of trouble. 
READ MORE >

Private equity-backed pharmaceutical company acquires stroke drug from Bayer

The drug, nimodipine, is a second-generation calcium channel blocker designed to prevent and treat cerebral vasospasm following an aneurysmal subarachnoid hemorrhage.

READ MORE >
private equity corporatization business consolidation
Share on Twitter Share on Facebook Share on Linkedin

Private equity-backed pharmaceutical company acquires stroke drug from Bayer

Share on Twitter Share on Facebook Share on Linkedin
private equity corporatization business consolidation
The drug, nimodipine, is a second-generation calcium channel blocker designed to prevent and treat cerebral vasospasm following an aneurysmal subarachnoid hemorrhage.
READ MORE >

Featured Articles

TAVR or SAVR? Where things stand now, from a surgeon's perspective

Kendra Grubb, MD, one of the country's leading experts on cardiac surgery, discussed what she tells her patients when they ask if TAVR is better than SAVR for treating severe aortic stenosis. 

READ MORE >
Kendra Grubb discusses TAVR vs SAVR and the most recent data to explain choices with patients.
Share on Twitter Share on Facebook Share on Linkedin

TAVR or SAVR? Where things stand now, from a surgeon's perspective

Share on Twitter Share on Facebook Share on Linkedin
Kendra Grubb discusses TAVR vs SAVR and the most recent data to explain choices with patients.
Kendra Grubb, MD, one of the country's leading experts on cardiac surgery, discussed what she tells her patients when they ask if TAVR is better than SAVR for treating severe aortic stenosis. 
READ MORE >

Cardiologists, heart surgeons and imaging experts push for changes that could prevent ‘permanent and unjustifiable Medicare cuts’

More than 100 U.S. medical societies are throwing their support behind a new proposal that could reform out-of-date Medicare policies and help limit future payment cuts. 

READ MORE >
Medicare money payment reimbursement dollar decline. More than 100 U.S. medical societies are throwing their support behind a new proposal that could reform out-of-date Medicare policies and help limit future payment cuts. 
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists, heart surgeons and imaging experts push for changes that could prevent ‘permanent and unjustifiable Medicare cuts’

Share on Twitter Share on Facebook Share on Linkedin
Medicare money payment reimbursement dollar decline. More than 100 U.S. medical societies are throwing their support behind a new proposal that could reform out-of-date Medicare policies and help limit future payment cuts. 
More than 100 U.S. medical societies are throwing their support behind a new proposal that could reform out-of-date Medicare policies and help limit future payment cuts. 
READ MORE >

CMS increases reimbursement for CVRx’s implantable Barostim device for heart failure

Implanting the Barostim device is now associated with an average payment amount of $45,000, up significantly from the previous average of $29,000.

READ MORE >
Barostim Neo 2 CVRx heart failure nerve stimulator on display at HRS 2023. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

CMS increases reimbursement for CVRx’s implantable Barostim device for heart failure

Share on Twitter Share on Facebook Share on Linkedin
Barostim Neo 2 CVRx heart failure nerve stimulator on display at HRS 2023. Photo by Dave Fornell
Implanting the Barostim device is now associated with an average payment amount of $45,000, up significantly from the previous average of $29,000.
READ MORE >

In Case You Missed It

PARTNER 3, Evolut and more: TAVR takes the spotlight in 4 late-breaking clinical trials at TCT 2023

All eyes were on TAVR during the first round of late-breaking clinical trials at TCT 2023 in San Francisco. Researchers shared key updates related to devices from Edwards Lifesciences, Medtronic, Boston Scientific and JenaValve Technology.

READ MORE >
TCT 2023 San Francisco
Share on Twitter Share on Facebook Share on Linkedin

PARTNER 3, Evolut and more: TAVR takes the spotlight in 4 late-breaking clinical trials at TCT 2023

Share on Twitter Share on Facebook Share on Linkedin
TCT 2023 San Francisco
All eyes were on TAVR during the first round of late-breaking clinical trials at TCT 2023 in San Francisco. Researchers shared key updates related to devices from Edwards Lifesciences, Medtronic, Boston Scientific and JenaValve Technology.
READ MORE >

FDA approves Medtronic’s extravascular ICD for abnormal heart rhythms

The Aurora EV-ICD MRI SureScan is similar in size and shape to traditional ICDs, but it is implanted outside of the patient’s heart and veins.

READ MORE >
Medtronic extravascular ICD Aurora EV-ICD MRI SureScan
Share on Twitter Share on Facebook Share on Linkedin

FDA approves Medtronic’s extravascular ICD for abnormal heart rhythms

Share on Twitter Share on Facebook Share on Linkedin
Medtronic extravascular ICD Aurora EV-ICD MRI SureScan
The Aurora EV-ICD MRI SureScan is similar in size and shape to traditional ICDs, but it is implanted outside of the patient’s heart and veins.
READ MORE >

In Other News

American Hospital Association sues HHS over IP tracking rule

The AHA is suing HHS over guidance that forbids the use of popular third-party tracking applications.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

American Hospital Association sues HHS over IP tracking rule

Share on Twitter Share on Facebook Share on Linkedin
The AHA is suing HHS over guidance that forbids the use of popular third-party tracking applications.
READ MORE >

Women with false-positive mammography results face increased risk of subsequent breast cancer

“Developing personalized surveillance programs can be beneficial for these women,” researchers detailed recently in JAMA Oncology. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Women with false-positive mammography results face increased risk of subsequent breast cancer

Share on Twitter Share on Facebook Share on Linkedin
“Developing personalized surveillance programs can be beneficial for these women,” researchers detailed recently in JAMA Oncology. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Cardiology's average salary rises | New hydroxychloroquine research | Heart transplants & COVID-19
Cardiology's average salary continues to rise | Exercise after a COVID-19 diagnosis | FDA fast-tracks HF medication
Electrophysiology & Arrhythmia | May 2020
New hydroxychloroquine research | How to prevent venous thromboembolism | Recycled pacemakers and defibrillators
Projections predict a rise in COVID-19 cases | Patient communication during the pandemic | Bill could forgive student loan debt
Hydroxychloroquine treatment for COVID-19 & QTc prolongation | Vascular Solutions recalls catheters
Practice Management | May 2020

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …343
    • Page 344
    • Page 345
    • Page 346
    • Current page 347
    • Page 348
    • Page 349
    • Page 350
    • Page 351 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup